Nevro (NVRO): Still behaving well

By Timothy Lutts, Chief Analyst, Cabot Stock of the Month
From Cabot Wealth Advisory 1/18/16 Sign up for Cabot Wealth Advisory—It’s free!

So far in this young year, a lot of people have been selling stocks, and the selling has accelerated as more and more people have joined the movement.

Nevertheless, there are very good reasons to hold onto stocks.

One is if you have large long-term gains and want to defer paying taxes on any capital gains.

Another is if your stock is still behaving well, supported by the buying power of investors just discovering the stock.

Nevro (NVRO), which has a revolutionary new pain management system based in spinal cord stimulation, is a good example of this. Nevro is a Cabot Top Ten Trader stock.